Front page
…encephalitis. Learn more News News Development of new ReaScan Mobile tests 16/08/2024 Duration12/2023 – 12/2025 Total Budget498 520 € EU fundig228 960 € Our company has received funding from the…
…encephalitis. Learn more News News Development of new ReaScan Mobile tests 16/08/2024 Duration12/2023 – 12/2025 Total Budget498 520 € EU fundig228 960 € Our company has received funding from the…
…well as an easy-to-use lateral flow test method. In this project, the company further developes this technology and new tests especially for at-home use. Responsible for publication Timo Ristola, CEO…
…fluid (CSF). For Lyme borreliosis diagnostics, Reagena has developed ReaScan+ C6 LYME IgG and ReaScan+ LYME IgM/IgG Combo rapid tests and Reagena C6 LYME IgM/IgG EIA enzyme immunoassay. These LYME…
…business.,” says Anu Mickels, Reagena’s CEO. The new visual identity is already on our new website. We would be interested to hear your thoughts on our new look. Give feedback…
Privacy Policy 1. Data controller Reagena Oy (”Reagena”) Business ID: 2495007-8 info@reagena.com Takojantie 18 70900 Toivala, Finland 2. Name of the register Reagena Oy’s customer and marketing register 3. Purpose and…
News News and events Read more News Development of new ReaScan Mobile tests 16/08/2024 Duration12/2023 – 12/2025 Total Budget498 520 € EU fundig228 960 € Our company has received funding…
…for new collaboration opportunities on scientific research projects and clinical testing. Got interested? Please contact our CTO Ilpo Kuronen, in order to discuss this further: ilpo.kuronen@reagena.com, tel. +358 45 1393757…
…cause hantavirus pulmonary syndrome (HPS). Hantavirus infection may be asymptomatic, or in worst cases, it can cause a lethal disease. Diagnostics for hantavirus infections – brochure Contact form “*” indicates…
…and implements them effectively. As a pioneer in the industry, Reagena develops high-quality immunological point-of-care tests, including ReaScan rapid tests and enzyme immunoassays tests. Reagena continuously gathers customer feedback during…
…Test Performance: PPA 94,8 % (CSF, serum/plasma) NPA 95,6 % (CSF, serum/plasma) EQV results counted as negative Product Code: 115103 ReaScan+ reader is sold separately (105100) Package Size: 10 Tests…